| dc.description.abstract | Background: Striae distensae (SD) is a skin disorder that become aesthetic concern
nowadays. To date there is no gold standart therapy for this disorder. Striae
distensae therapy aims to induce dermal collagen production, repair tissue strength,
increasing of elasticity and skin hydration. Green tea (Camellia sinensis linn) is a
herbal product that gain recognition because of its advantage for skin. Green tea
contain catechin, phenolic acid, ascorbic acid and linoleate acid which play a role
in the repair of SD benefit in anti-inflammatory mechanisms, antioxidant activity,
stimulates fibroblast proliferation, epithelialization and collagen synthesis.
Objetive: To determine the effect of 3% green tea extract cream (Camellia sinensis
linn) on striae distensae.
Methods: This pre-experimental clinical trial study was conducted with a pretestposttest
design on 36 striae distensae subjects. Diagnosis was made through history
taking and clinical evaluation. INA score was used as evaluation for SD severity
before and after the administration of 3% green tea extract cream, carried out at
weeks 0, 2, 4, 6, and 8. Side effects and satisfaction levels were recorded during
study. Cochran test was carried out to see the difference before and after treatment
with a p-value <0.05, is considered significant.
Results: The majority of the subjects age ranged from 18 to 25 years (77.8%), the
majority of subjects had history of pregnancy (75%), the majority of subjects had a
history of menarche at the age of 12 years (27.8%) and all subjects had striae alba
(100%). There was significant decrease in INA score for patient with striae
distensae (p<0.001) after eight weeks administration of 3% green tea extract cream.
Clinical improvement and no side effects were also noted. Based on the level of
satisfaction all subjects feel satisfied.
Conclusion: The use of 3% green tea extract cream can improve the appearance of
SD and the use of this extract showed no side effects and all of the subjects feel
satisfied. | en_US |
